Targeted cytotoxic therapy kills persisting HIV infected cells during ART
about
Animal Models for HIV Cure ResearchStudies of retroviral infection in humanized miceTowards an HIV cure based on targeted killing of infected cells: different approaches against acute versus chronic infectionStructural basis for the inhibition of HIV-1 Nef by a high-affinity binding single-domain antibodyUsing animal models to overcome temporal, spatial and combinatorial challenges in HIV persistence researchAre T cells the only HIV-1 reservoir?Bioinformatics and HIV latency.Latency reversal and viral clearance to cure HIV-1.When noise makes music: HIV reactivation with transcriptional noise enhancers.The potential of radioimmunotherapy as a new hope for HIV patients.HIV-1 DNA predicts disease progression and post-treatment virological control.Exploring the potential of monoclonal antibody therapeutics for HIV-1 eradication.Translational challenges in targeting latent HIV infection and the CNS reservoir problem.Dynamics of HIV latency and reactivation in a primary CD4+ T cell model.Eradicating HIV-1 infection: seeking to clear a persistent pathogen.Humanized mouse models for HIV-1 infection of the CNS.Vectored antibody gene delivery for the prevention or treatment of HIV infection.HIV pre-exposure prophylaxis: mucosal tissue drug distribution of RT inhibitor Tenofovir and entry inhibitor Maraviroc in a humanized mouse model.Specific Elimination of Latently HIV-1 Infected Cells Using HIV-1 Protease-Sensitive Toxin Nanocapsules.A Murine Viral Outgrowth Assay to Detect Residual HIV Type 1 in Patients With Undetectable Viral LoadsDual-Affinity Re-Targeting proteins direct T cell-mediated cytolysis of latently HIV-infected cells.Human Immunodeficiency Virus Type 1 Monoclonal Antibodies Suppress Acute Simian-Human Immunodeficiency Virus Viremia and Limit Seeding of Cell-Associated Viral Reservoirs.In vivo platforms for analysis of HIV persistence and eradication.Towards HIV-1 remission: potential roles for broadly neutralizing antibodies.Recent developments in the effort to cure HIV infection: going beyond N = 1.Improvements and Limitations of Humanized Mouse Models for HIV Research: NIH/NIAID "Meet the Experts" 2015 Workshop Summary.ART influences HIV persistence in the female reproductive tract and cervicovaginal secretions.Macrophages sustain HIV replication in vivo independently of T cellsCD19xCD3 DART protein mediates human B-cell depletion in vivo in humanized BLT miceHIV cure research: a formidable challengeCombination of Antiretroviral Drugs and Radioimmunotherapy Specifically Kills Infected Cells from HIV-Infected Individuals.Design and In Vivo Characterization of Immunoconjugates Targeting HIV gp160.Identification of Human Anti-HIV gp160 Monoclonal Antibodies That Make Effective Immunotoxins.Predicting HIV Pre-exposure Prophylaxis Efficacy for Women using a Preclinical Pharmacokinetic-Pharmacodynamic In Vivo Model.International AIDS Society global scientific strategy: towards an HIV cure 2016.Targeting HIV latency: resting memory T cells, hematopoietic progenitor cells and future directions.Finding a cure for human immunodeficiency virus-1 infection.The future of antiviral immunotoxins.Engineering broadly neutralizing antibodies for HIV prevention and therapy.Humanized mice for HIV and AIDS research.
P2860
Q26767476-31441D69-9885-40B9-B2B6-2D755F773156Q26849806-E42C8AC3-8311-4149-95A1-714E4F49B08EQ27005830-2F8A951C-1BAE-4927-88AD-2D984B7FE941Q27682132-FF9CA39A-9837-47A4-BEFA-140BD858CBB5Q28077662-C9C5AEF1-D956-40A5-86A0-B6137AF13875Q28078850-6B3EF6E0-9296-413F-BBC5-58630016F0FFQ28081427-450C174A-D50B-4175-98DA-89096A8CEC59Q30248766-C77DD25D-5F53-4700-B0C2-4EF0FEF97929Q30367371-A263F4E4-1189-415B-891E-4BB465A391A6Q33863509-E266A8DE-7603-4150-A252-8AE7F037817AQ34350410-882E2FF5-475E-4098-86F8-A959889727E7Q34869927-34BF4519-BC3F-4836-82FC-A11C062817D0Q35009744-C7FE298E-917B-4B39-AFB8-CE37B80B47FEQ35176166-B3321B16-7E1C-4574-AF86-4769EA58D322Q35252186-C664AEB2-83DD-4AA1-B765-00483D7C1F85Q35567215-D451D059-9766-4FAE-BB81-AE80C6AC1151Q35664155-2EE0CBCF-938B-424F-B40A-6FC9A8739D7EQ35794988-266D15D0-1FEE-41B5-9268-ED92325DA779Q35980789-9FBFB5AF-7544-47A9-9005-F3D726EB31D6Q36149000-9783E1BE-65C0-49FA-882E-3CA8F2ABAE31Q36266486-1F5675A1-5F21-4EE9-8D02-54A70C471310Q36481483-CEE1BA7E-3D12-4868-BBBC-32BDDDC46C8FQ36515119-60843BC9-49D6-49A5-9AC5-369ED73B2543Q36515149-58F06B9C-9400-421C-AB06-FD62C6A52296Q36515170-B3C10E07-0AFF-4032-986B-1B363225CB6DQ36601983-3DB66E02-E457-43A0-ADFB-56BE4FB456D4Q36618563-54EAFF38-99CD-4701-9838-EF357E9FA6FAQ36737917-A20FEC5A-6CD5-4DDA-8386-69621463B7D3Q36777155-7A3245D4-DBEA-475C-86ED-8D26219AC22EQ37098202-3A325663-7922-440B-8A81-04DF99E3B51BQ37281138-282C88C9-1C18-4FE4-9AEF-083FCE0BE05AQ37593171-677FD6F4-946B-4920-AE3B-B9B15DF30B40Q37593177-B3A11202-801D-4771-AF01-6FD32ABCF406Q37618260-37CCC0DA-A2B3-4D88-A3B4-1F28DBDEE842Q37661770-393FE24D-9F1D-40B2-8493-139A4D0778CEQ38246141-02EC6574-A52F-4389-9A14-A0BEEAD9E9BBQ38256237-D8DE5668-D901-4FEF-AFD1-2150DD3CAD63Q38686601-0FE64B57-4D0C-4054-B1DD-6EA2C41F202EQ38717198-ED5A2D73-40ED-4F07-B295-4B37877C39A1Q38838864-46A7A451-6FBF-4D9B-97CD-0C75D407CF55
P2860
Targeted cytotoxic therapy kills persisting HIV infected cells during ART
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Targeted cytotoxic therapy kills persisting HIV infected cells during ART
@ast
Targeted cytotoxic therapy kills persisting HIV infected cells during ART
@en
Targeted cytotoxic therapy kills persisting HIV infected cells during ART
@nl
type
label
Targeted cytotoxic therapy kills persisting HIV infected cells during ART
@ast
Targeted cytotoxic therapy kills persisting HIV infected cells during ART
@en
Targeted cytotoxic therapy kills persisting HIV infected cells during ART
@nl
prefLabel
Targeted cytotoxic therapy kills persisting HIV infected cells during ART
@ast
Targeted cytotoxic therapy kills persisting HIV infected cells during ART
@en
Targeted cytotoxic therapy kills persisting HIV infected cells during ART
@nl
P2093
P2860
P3181
P1433
P1476
Targeted cytotoxic therapy kills persisting HIV infected cells during ART
@en
P2093
Angela D Kashuba
Ashley T Haase
Craig Sykes
Edward A Berger
Ira Pastan
J Victor Garcia
Julie M Long
Katherine Perkey
Michael G Hudgens
P2860
P304
P3181
P356
10.1371/JOURNAL.PPAT.1003872
P407
P577
2014-01-01T00:00:00Z